Literature DB >> 11918563

A survey of one-stage and chromogenic potencies in therapeutic factor VIII concentrates.

Anthony R Hubbard, Lynne J Weller, Sally A Bevan.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11918563     DOI： 10.1046/j.1365-2141.2002.3406_1.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients.

Authors:  Hendrika Hazendonk; Karin Fijnvandraat; Janske Lock; Mariëtte Driessens; Felix van der Meer; Karina Meijer; Marieke Kruip; Britta Laros-van Gorkom; Marjolein Peters; Saskia de Wildt; Frank Leebeek; Marjon Cnossen; Ron Mathôt
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

2.  Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.

Authors:  Steffen Rosen; Stefan Tiefenbacher; Mary Robinson; Mei Huang; Jaydeep Srimani; Donnie Mackenzie; Terri Christianson; K John Pasi; Savita Rangarajan; Emily Symington; Adam Giermasz; Glenn F Pierce; Benjamin Kim; Stephen J Zoog; Christian Vettermann
Journal:  Blood       Date:  2020-11-26       Impact factor: 22.113

3.  Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study.

Authors:  Stefan Tiefenbacher; Manuela Albisetti; Peter Baker; Guenther Kappert; Steve Kitchen; Johanna A Kremer Hovinga; Claire Pouplard; Ute Scholz; Catherine Ternisien; Carin Borgvall; Tiago Vicente; Larisa Belyanskaya; Olaf Walter; Johannes Oldenburg
Journal:  Haemophilia       Date:  2019-05-20       Impact factor: 4.287

4.  Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?

Authors:  Tine M H J Goedhart; Laura H Bukkems; Iris van Moort; Colin C Spence; Michel C Zwaan; Moniek P M de Maat; Ron A A Mathôt; Marjon H Cnossen
Journal:  Haemophilia       Date:  2022-05-08       Impact factor: 4.263

5.  Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories.

Authors:  J M Sommer; N Moore; B McGuffie-Valentine; S Bardan; Y Buyue; G D Kamphaus; B A Konkle; G F Pierce
Journal:  Haemophilia       Date:  2013-11-22       Impact factor: 4.287
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.